Recent Press Releases

Genisphere Closes $2 Million to Accelerate Development of Targeted Drug Delivery Platform

HATFIELD, Pa., Sep 16, 2014 (BUSINESS WIRE) -- Genisphere LLC, provider of the 3DNA® nanotechnology platform, reported today it has closed $2 million in private funding from existing investors,...

RNA Therapeutics Market is Expected to Reach $1.2 Billion, Globally, by 2020 - Allied Market Research

A new report by Allied Market Research, titled "RNA Therapeutics Market (technology, applications, end user and geography) - Industry Analysis and Forecast, 2013 - 2020", suggests that the...

Novaliq GmbH Announces Positive Results from NovaTears® Observational Study in Mild to Moderate Evaporative Dry Eye Disease

HEIDELBERG, Germany--(BUSINESS WIRE)--Novaliq GmbH, a drug delivery company focusing on the topical application of ophthalmic technologies for poorly soluble drugs, today announced that its observational study NT-001, which placed NovaTears® OTC eye drops in 30 patients with symptoms of mild to moderate evaporative dry eye disease, successfully demonstrated effectiveness and safety in relief of dry eye symptoms.

Liquidia Announces Formation of Lq3 Pharmaceuticals, an Oral Health Company

RESEARCH TRIANGLE PARK, N.C.--()--Liquidia Technologies today announced the formation of a new pharmaceutical company, Lq3 Pharmaceuticals, dedicated to advancing novel therapies for...

UK based drug delivery specialist, Q Chip, launches ocular spin-out, OpsiRx Pharmaceuticals, reports significant progress and appoints new Chairman

Q Chip's Board made the following announcement today: · Q Chip has launched OpsiRx Pharmaceuticals Ltd ("OpsiRx"), the ophthalmology company developing products...

Miriam Hospital among National Research Group Awarded $20 Million NIH Grant

9/8/2014 • Funding to be used for creation of drug delivery system to prevent HIV infection in women Miriam Hospital among National Research GroupThe Miriam Hospital is part of a research...

Rexahn Receives a Notice of Allowance from the U.S. Patent and Trademark Office for a Novel Targeted Cancer Drug Delivery Platform

Rexahn Receives a Notice of Allowance from the U.S. Patent and Trademark Office for a Novel Targeted Cancer Drug Delivery Platform Company expands its pipeline of breakthrough drug delivery...

Elekta: Elekta's Versa HD Radiation Therapy System Now Available for Treatment of Cancer Patients in Japan

STOCKHOLM--()--Regulatory News: "The Ministry's clearance of Versa HD is an important step in addressing serious increases in cancer incidences and deaths in Japan"...

BioTime to Collaborate With the University of Wisconsin and Louvain University in Test of HyStem(R) -Based Hydrogel for Vocal Fold Scarring

Investigator-initiated clinical trial may follow preclinical studies ALAMEDA, Calif.--(BUSINESS WIRE)--August 28, 2014-- BioTime, Inc. (NYSE MKT:BTX) today announced that it has entered into a...

Needle-Free Delivery Devices Shape the Future of Vaccines, Says Frost & Sullivan

LONDON, Sept. 2, 2014 /PRNewswire/ -- Drug delivery technologies that improve access and overall efficacy are becoming an essential part of the entire drug development process. Pharmaceutical...

Genoa Pharmaceuticals Receives Orphan-Drug Designation for Pirfenidone in the Inhaled Treatment of Idiopathic Pulmonary Fibrosis (IPF)

SAN DIEGO, Aug. 5, 2014 /PRNewswire/ -- Genoa Pharmaceuticals, the leader in inhaled medicines for pulmonary fibrosis, today announced the U.S. Food and Drug Administration (FDA) has granted...

Fresenius Kabi Receives FDA approval for Kabiven and Perikabiven

First and only three-chamber bag available in the United States for parenteral nutrition LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today it has received approval from the U.S....

AB SCIEX and Dalton Pharma Services Collaborate to Advance Antibody-Drug Conjugate Analysis

TORONTO--()--AB SCIEX and Dalton Pharma Services (Dalton) announced today a research collaboration to develop Antibody-Drug Conjugate (ADC) analysis capabilities. This will include...

Cenix BioScience and Metanomics Health Sign Research Agreement

Cenix BioScience GmbH, a leading preclinical contract research provider and technology developer specialized in genome-scale gene modulation studies and high throughput, high content pharmacology,...

Louisiana Tech researchers use 3D printers to create custom medical implants

Breakthrough technology creates materials infused with cancer-fighting drugs, antibiotics August 20, 2014 A team of researchers at Louisiana Tech University has developed an innovative method for...

EastGate Acquisitions Augments Its Sub-Micron Self-Nanoemulsifying Platform Technology

SALT LAKE CITY and TORONTO, Aug. 18 , 2014 /PRNewswire/ -- EastGate Acquisitions Corporation (OTCBB: ESAQ), an emerging pharmaceutical company exploring drug delivery innovations in the development...

Depomed Prevails in Gralise® ANDA Litigation Blocking Generic Entry Until 2024

NEWARK, Calif., Aug. 19, 2014 /PRNewswire/ -- Depomed, Inc. (Nasdaq: DEPO) today announced Judge Joel A. Pisano of the U.S. District Court for the District of New Jersey has ruled in favor of Depomed...

Stimuli-Responsive Drug Delivery System Prevents Transplant Rejection, Reduces Toxicity, and Lasts for Months

Press Release - Aug 13, 2014 Boston, MA - Following a tissue graft transplant-such as that of the face, hand, arm or leg-it is standard for doctors to immediately give transplant recipients...

FDA Advisory Committee Recommends Approval of Tiotropium Respimat for the Maintenance Treatment of COPD

Published: Aug 14, 2014 4:35 p.m. ET Committee Voted Based on Clinical Data from Eight Efficacy Trials RIDGEFIELD, Conn., Aug. 14, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc....

Arrowhead Reports Fiscal 2014 Third Quarter Financial Results and Provides Update on ARC-520

August 12, 2014 04:01 PM Eastern Daylight Time PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics,...